New drug trial seeks to control tough blood cancers
Disease control
Ongoing
This early-stage study is testing a new drug called KQB198, given alone or with other cancer drugs, in adults with advanced blood cancers. The main goals are to find a safe dose and see if it helps shrink tumors. Researchers will also track how the body processes the drug and mon…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Apr 02, 2026 01:41 UTC